SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

71,913.50 -566.79
( -0.78%)

Global Indices

Nasdaq

50,945.10 -425.82
(-0.83%)

Dow Jones

7,674.56 -17.28
(-0.22%)

Hang Seng

68,949.71 2,195.99
(3.29%)

Nikkei 225

10,610.72 -25.99
(-0.24%)

Forex

USD-INR

95.97 0.01
(0.01%)

EUR-INR

108.89 -0.26
(-0.24%)

GBP-INR

126.98 -0.19
(-0.15%)

JPY-INR

0.61 0.00
(0.01%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Dr Reddys Laboratories Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

500124

INE089A01031

377.9539136

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

DRREDDY

155.47

103166.48

EPS(TTM)

Face Value()

Div & Yield %

7.95

0.65

Back

Bosch consolidated net profit declines 36.74% in the June 2026 quarter

Aug 11,2026

Net profit of Bosch declined 36.74% to Rs 706.10 crore in the quarter ended June 2026 as against Rs 1116.10 crore during the previous quarter ended June 2025. Sales rose 22.00% to Rs 5841.90 crore in the quarter ended June 2026 as against Rs 4788.60 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	5841.90	4788.60	22
OPM %	14.06	13.35	-
PBDT	1040.70	922.80	13
PBT	941.80	837.80	12
NP	706.10	1116.10	-37

71,913.50 -566.79 ( -0.78%)

50,945.10 -425.82 (-0.83%)

7,674.56 -17.28 (-0.22%)

68,949.71 2,195.99 (3.29%)

10,610.72 -25.99 (-0.24%)

95.97 0.01 (0.01%)

108.89 -0.26 (-0.24%)

126.98 -0.19 (-0.15%)

0.61 0.00 (0.01%)